Production of functional recombinant G-protein coupled receptors for heteromerization studies

被引:7
作者
Cavic, Milena [1 ]
Lluis, Carme [2 ,3 ]
Moreno, Estefania [2 ,3 ]
Bakesova, Jana [2 ,3 ]
Canela, Enric I. [2 ,3 ]
Navarro, Gemma [2 ,3 ]
机构
[1] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade 11000, Serbia
[2] Univ Barcelona, Fac Biol, CIBERNED, E-08028 Barcelona, Spain
[3] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
关键词
Heteromer; Adenosine; Dopamine; Histamine; Cloning; Parkinson's disease; HISTAMINE H-3;
D O I
10.1016/j.jneumeth.2011.05.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
G-protein-coupled receptors (GPCRs) represent a diverse protein family of receptors that transduce signals from the extracellular surrounding to intracellular signaling molecules evoking various cellular responses. It is now widely accepted that GPCRs are expressed and function as dimers or most probably as oligomers of more than two receptor protomers. The heteromer has different biochemical and pharmacological characteristics from the monomers, which increases the functional responses of GPCRs. GPCRs are involved in many diseases, and are also the target of around half of all modern medicinal drugs. In the case of Parkinson's disease, a degenerative process caused by gradual disappearance of dopaminergic nigrostriatal neurons, it is suspected that the targets for treatment should be dopamine-receptor-containing heteromers. Technologies based on the use of fluorescent- or luminescent-fused receptors and adaptations of resonance energy transfer (RET) techniques have been useful in investigating the functional inter-relationships between receptors in a heteromer. In this study functional recombinant adenosine A(2A)-Rluc, dopamine D(2)-GFP(2) and histamine H(3)-YFP receptor fusion proteins were successfully cloned and characterized, producing the essential basis for heteromerization studies between these receptors. This might provide a better insight into their pharmacological and functional inter-relationships in the brain and enable the design and evaluation of new therapeutic strategies for Parkinson's disease. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 12 条
  • [1] Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation
    Bulenger, S
    Marullo, S
    Bouvier, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (03) : 131 - 137
  • [2] Adenosine A2A-dopamine D2 receptor-receptor heteromerization -: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
    Canals, M
    Marcellino, D
    Fanelli, F
    Ciruela, F
    de Benedetti, P
    Goldberg, SR
    Neve, K
    Fuxe, K
    Agnati, LF
    Woods, AS
    Ferré, S
    Lluis, C
    Bouvier, M
    Franco, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) : 46741 - 46749
  • [3] Detection of heteromerization of more than two proteins by sequential BRET-FRET
    Carriba, Paulina
    Navarro, Gemma
    Ciruela, Francisco
    Ferre, Sergi
    Casado, Vicent
    Agnati, Luigi
    Cortes, Antoni
    Mallol, Josefa
    Fuxe, Kjell
    Canela, Enric I.
    Lluis, Carmen
    Franco, Rafael
    [J]. NATURE METHODS, 2008, 5 (08) : 727 - 733
  • [4] Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function
    Ferrada, Carla
    Ferre, Sergi
    Casado, Vicent
    Cortes, Antonio
    Justinova, Zuzana
    Barnes, Chanel
    Canela, Enric I.
    Goldberg, Steven R.
    Leurs, Rob
    Lluis, Carme
    Franco, Rafael
    [J]. NEUROPHARMACOLOGY, 2008, 55 (02) : 190 - 197
  • [5] Ferre Sergi, 2007, ScientificWorldJournal, V7, P74
  • [6] Franco Rafael, 2007, ScientificWorldJournal, V7, P48
  • [7] Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity
    Franco, Rafael
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (08) : 983 - 987
  • [8] Heterodimers and Receptor Mosaics of Different Types of G-Protein-Coupled Receptors
    Fuxe, Kjell
    Marcellino, Daniel
    Guidolin, Diego
    Woods, Amina S.
    Agnati, Luigi F.
    [J]. PHYSIOLOGY, 2008, 23 (06) : 322 - 332
  • [9] GILCHRIST A, 2010, GPCR MOL PHARM DRUG, P191
  • [10] The histamine H3 receptor:: From gene cloning to H3 receptor drugs
    Leurs, R
    Bakker, RA
    Timmerman, H
    de Esch, IJP
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) : 107 - U18